Suchergebnisse - "Aoki, Daisuke"

PubPharm (23)

1

Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial

enthalten in: Gynecologic oncology | 2019

von Nomura, H. | Aoki, D. | Susumu, N. | +10

2

Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma

enthalten in: Cancer science | 2019

von Okazaki, S. | Umene, K. | Yamasaki, J. | +11

3

Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells

enthalten in: Human cell | 2019

von Tanaka, K. | Kiguchi, K. | Mikami, M. | +2

4

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2019

von Nomura, H. | Aoki, D. | Michimae, H. | +15

CommentIn: Transl Cancer Res. 2019 Oct;8(6):2220-2222. - PMID 35116974

5

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

enthalten in: British journal of cancer | 2018

von Aoki, Y. | Ochiai, K. | Lim, S. | +17

6

ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death

enthalten in: Cancer science | 2018

von Ueno, M. | Shiomi, T. | Mochizuki, S. | +8

7

Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer

enthalten in: International journal of clinical oncology | 2016

von Shimada, M. | Sato, S. | Oishi, T. | +7

8

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma : JGOG3017/GCIG Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Sugiyama, T. | Okamoto, A. | Enomoto, T. | +21

9

Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer

enthalten in: International journal of clinical oncology | 2016

von Shimada, M. | Sato, S. | Oishi, T. | +7

10

Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer

enthalten in: International journal of clinical oncology | 2016

von Shimada, M. | Sato, S. | Oishi, T. | +7